A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.
Why choose Austin for clinical trials?
Austin, Texas, provides distinct advantages for those participating in clinical trials. The city’s vibrant and diverse population offers a rich pool of participants, enhancing the accuracy and applicability of research findings. Austin is renowned for its innovative medical research environment, driven by leading institutions that focus on pioneering advancements and cutting-edge studies.
By joining a clinical trial in Austin, participants not only contribute to significant medical research but also benefit from a highly collaborative and supportive clinical research ecosystem. The city’s commitment to advancing healthcare through research ensures that participants are involved in meaningful studies that push the boundaries of medical science.
Common conditions studied in Austin
In Austin, clinical trials address a broad spectrum of medical conditions, reflecting the city’s commitment to advancing healthcare through innovative research and specialized facilities.
Diabetes
Austin is a leading hub for diabetes research, with institutions such as the Texas Diabetes Institute and Dell Medical School conducting extensive trials. These studies focus on developing new insulin formulations, advanced glucose monitoring technologies, and innovative treatments aimed at both Type 1 and Type 2 diabetes.
Trials often explore combination therapies that integrate lifestyle changes, diet modifications, and cutting-edge pharmaceuticals to optimize glycemic control and enhance quality of life for patients.
Cancer
The Austin Cancer Center and Dell Medical School are prominent in the field of oncology, with clinical trials investigating a range of cancers including breast, prostate, and lung cancer.
These trials are at the forefront of exploring new immunotherapies, which harness the body’s immune system to target cancer cells more effectively, and targeted therapies that focus on specific genetic mutations. Additionally, cancer clinical trials often test new combinations of chemotherapy, radiation, and emerging drug therapies to improve treatment efficacy and reduce side effects.
Neurological disorders
Neurological research in Austin is concentrated on conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). Clinical trials frequently involve testing novel drug treatments aimed at slowing disease progression, exploring new biomarkers for early diagnosis, and utilizing advanced imaging techniques to better understand disease mechanisms.
Trials may also assess the effectiveness of non-pharmacological interventions, including cognitive therapies and rehabilitation approaches.
Cardiovascular diseases
Austin’s clinical trials in cardiovascular research target a variety of conditions including hypertension, heart failure, and coronary artery disease. Studies often focus on the development of new pharmacological treatments, innovative surgical techniques, and preventive strategies to manage risk factors.
Cardiovascular clinical trials might also explore the use of new drug classes, such as novel anticoagulants or lipid-lowering agents, as well as minimally invasive procedures like catheter-based interventions and improvements in cardiac imaging.
Autoimmune disorders
Clinical trials in Austin also address autoimmune diseases such as rheumatoid arthritis, hidradenitis suppurativa and lupus. Research here investigates new biologic therapies that specifically target immune system components involved in disease pathology, as well as other immune-modulating treatments. Trials often explore the efficacy of these new treatments in reducing inflammation, managing symptoms, and improving overall disease management.
Local regulations and guidelines
In Austin, clinical trials are governed by a comprehensive set of regulations ensuring ethical conduct and participant safety. Researchers must adhere to federal guidelines from the FDA and HHS, including compliance with Title 21 of the Code of Federal Regulations, which covers aspects like informed consent, IRB approval, and Good Clinical Practice.
Institutional Review Boards (IRBs) are responsible for reviewing and approving study protocols to ensure they meet ethical standards and protect participants. Additionally, Texas state regulations, overseen by the Texas Medical Board and Health and Human Services Commission, complement federal requirements. Trials must also comply with HIPAA to safeguard participant privacy and data.
Benefits of participating in clinical trials
Volunteering in a clinical trial provides the exclusive opportunity to access innovative treatments and therapies ahead of their general release. Participants in a clinical trial will receive specialized care from leading healthcare professionals who offer personalized attention and detailed monitoring throughout the research.
Involvement in clinical trials is essential for advancing medical science and can result in important breakthroughs in both treatment and prevention. By taking part, individuals contribute significantly to the development of new medical knowledge, helping to enhance future healthcare outcomes for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Austin
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.